688315.SH
Novogene Co., Ltd.
SSE · Healthcare · Biotechnology · CN
CNY 16.93
+6.14%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 29.13x
- P/E 2027E
- 25.68x
- P/E 2028E
- 22.61x
- P/S forward
- 5.47x
Trailing multiples
Trailing twelve months
- P/E TTM
- 42.21x
- PEG TTM
- 1.17x
- Price / book
- 2.65x
- Price / sales
- 2.79x
- Price / cash flow
- 25.54x
Enterprise value
- Enterprise value
- CNY 6.0B
- EV / sales
- 2.66x
- EV / EBITDA
- 18.50x
- EV / EBIT
- 31.26x
- Market cap
- CNY 7.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026